FDA OKs first drug made to reduce excessive sweating

June 29, 2018 by Linda A. Johnson
FDA OKs first drug made to reduce excessive sweating
This undated image provided by Dermira Inc. shows the drug Qbrexz. The U.S. Food and Drug Administration approved Qbrexza, the first drug developed to reduce excessive sweating, a common condition that can cause anxiety. Maker Dermira Inc. said Friday, June 29, 2018, that its drug was approved for excessive underarm sweating. (Dermira Inc. via AP)

U.S. regulators on Friday approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives.

The Food and Drug Administration approved Qbrexza for excessive underarm sweating and will be available in October. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.

Its manufacturer, Dermira Inc., refused to disclose the price, as drugmakers normally do.

An estimated 15.3 million Americans have some form of excessive sweating, but only 1 in 4 get treatment. Current treatment options include Botox injections, surgery to remove sweat glands, procedures using lasers and other devices, and drugs approved for other conditions that block the body's chemical messengers to reduce sweat production throughout the body.

Side effects of Qbrexza include blurred vision, constipation, burning and itchy skin, head and throat pain, and dry mouth, eyes and skin.

Dermira said in one study, 53 percent of patients reported Qbrexza reduced sweat production by roughly half, versus 28 percent in a comparison group using a nonmedicated cloth.

Explore further: FDA approves first generic under-the-tongue suboxone

Related Stories

FDA approves first generic under-the-tongue suboxone

June 18, 2018
(HealthDay)—The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration.

For some, too much sweat takes emotional toll

April 6, 2017
(HealthDay)—Don't sweat the small stuff. That's sound advice for most—but not if you're one of the 7 million Americans diagnosed with hyperhidrosis.

FDA approves Botox for migraine headaches

October 15, 2010
(AP) -- Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches on Friday, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of the ...

Botox now used for urinary incontinence

March 14, 2012
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the U.S. Food and Drug Administration (FDA) approved using the injections to help patients ...

Scientists unravel the mystery of a rare sweating disorder

October 20, 2014
An international research team discovered that mutation of a single gene blocks sweat production, a dangerous condition due to an increased risk of hyperthermia, also known as heatstroke. The gene, ITPR2, controls a basic ...

First drug approved for most common inherited kidney disease

April 24, 2018
The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease.

Recommended for you

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.